US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neo-Concept International Group Holdings Limited

0.7561

-0.0739-8.90%

Post-market: 0.7151-0.0410-5.42%19:54 EDT

Volume:2.25M

Turnover:1.57M

Market Cap:14.30M

PE:2.78

High:0.7650

Open:0.6200

Low:0.6200

Close:0.8300

52wk High:13.81

52wk Low:0.3200

Shares:18.91M

Float Shares:945.20K

Volume Ratio:0.38

T/O Rate:238.49%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2723

EPS(LYR):0.2648

ROE:16.08%

ROA:6.19%

PB:1.93

PE(LYR):2.86

Loading ...

Overview Company News Filings

JACOBIO-B (01167) Presents Preclinical Data for Pan-KRAS Inhibitor JAB-23E73 at the 2025 AACR-NCI-EORTC International Conference

BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference

ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference

HUTCHMED (00013) Unveils HMPL-A251 Data at AACR-NCI-EORTC Conference

HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Arvinas to Present Preclinical Data for ARV-806, a PROTAC KRAS G12D Degrader, at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025

I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference

Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Avacta to Present First Dual Payload pre|CISION® Medicines Data at the 2025 EORTC-NCI-AACR International Conference on Molecular Targets Symposium

3 Apparel Stocks See Sharp Drop In Momentum Rankings This Week

Benzinga_recent_news

Shell third quarter 2025 update note

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NCI/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NCI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NCI\",,,,,undefined,":{"symbol":"NCI","market":"US","secType":"STK","nameCN":"Neo-Concept International Group Holdings Limited","latestPrice":0.7561,"timestamp":1775160000000,"preClose":0.83,"halted":0,"volume":2254172,"hourTrading":{"tag":"盘后","latestPrice":0.7151,"preClose":0.7561,"latestTime":"19:54 EDT","volume":102349,"amount":74809.662,"timestamp":1775174098375,"change":-0.041,"changeRate":-0.054226,"amplitude":0.052903},"delay":0,"changeRate":-0.08903614457831321,"floatShares":945200,"shares":18914018,"eps":0.272333,"marketStatus":"Market Closed","change":-0.0739,"latestTime":"04-02 16:00:00 EDT","open":0.62,"high":0.765,"low":0.62,"amount":1570675.2657748,"amplitude":0.174699,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.272333,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1713844800000,"exchange":"NASDAQ","adjPreClose":0.83,"preHourTrading":{"tag":"盘前","latestPrice":0.67,"preClose":0.83,"latestTime":"09:27 EDT","volume":122853,"amount":80049.86612445001,"timestamp":1775136478351,"change":-0.16,"changeRate":-0.192771,"amplitude":0.068675},"postHourTrading":{"tag":"盘后","latestPrice":0.7151,"preClose":0.7561,"latestTime":"19:54 EDT","volume":102349,"amount":74809.662,"timestamp":1775174098375,"change":-0.041,"changeRate":-0.054226,"amplitude":0.052903},"volumeRatio":0.38288084636640995},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NCI\",,,,,undefined,":{"symbol":"NCI","floatShares":945200,"roa":"6.19%","roe":"16.08%","lyrEps":0.264768,"volumeRatio":0.38288084636640995,"shares":18914018,"dividePrice":0,"high":0.765,"amplitude":0.174699,"preClose":0.83,"low":0.62,"week52Low":0.32,"pbRate":"1.93","psRate":"0.52","week52High":13.81,"institutionHeld":0.7857,"latestPrice":0.7561,"eps":0.272333,"divideRate":0,"volume":2254172,"delay":0,"ttmEps":0.272333,"open":0.62,"prevYearClose":1.13,"prevWeekClose":5.77,"prevMonthClose":1.78,"prevQuarterClose":1.78,"fiveDayClose":5.96,"twentyDayClose":10.5,"sixtyDayClose":1.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NCI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-06-16","symbol":"NCI","defaultRemindTime":1750080600000,"type":"split","dateTimestamp":1750046400000,"forFactor":5,"toFactor":1,"ratio":5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NCI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NCI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NCI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NCI","date":"2026-04-02","current":2.77638,"percent":0.61807,"low":-615.963293,"twenty":5.599593,"median":8.843088,"eighty":23.069529,"high":204.456852,"avg":14.332838,"sd":46.152669,"marketCap":15698634},"quantilePoints":[{"date":"2024-04-26","current":-152.934443,"twenty":-421.533502,"median":-222.424043,"eighty":-152.416021,"marketCap":47955200},{"date":"2024-05-03","current":-75.704037,"twenty":-208.526123,"median":-121.807344,"eighty":-81.702314,"marketCap":23774400},{"date":"2024-05-10","current":-74.39805,"twenty":-152.15681,"median":-81.565326,"eighty":-71.297323,"marketCap":23368000},{"date":"2024-05-17","current":36.631419,"twenty":-133.739762,"median":-74.39805,"eighty":-23.514082,"marketCap":20726400},{"date":"2024-05-24","current":30.19238,"twenty":-105.051475,"median":-71.169081,"eighty":36.421773,"marketCap":17068800},{"date":"2024-05-31","current":25.951993,"twenty":-89.228644,"median":-65.79629,"eighty":35.854613,"marketCap":14650720},{"date":"2024-06-07","current":26.211896,"twenty":-81.702314,"median":25.015338,"eighty":34.642796,"marketCap":14813280},{"date":"2024-06-14","current":29.519581,"twenty":-78.809845,"median":25.103888,"eighty":32.998302,"marketCap":16682720},{"date":"2024-06-21","current":25.962557,"twenty":-75.44284,"median":25.889128,"eighty":31.491027,"marketCap":14685264},{"date":"2024-06-28","current":22.645555,"twenty":-74.134092,"median":25.192438,"eighty":30.05782,"marketCap":12803632},{"date":"2024-07-05","current":22.365126,"twenty":-73.07826,"median":25.015338,"eighty":29.519581,"marketCap":12639040},{"date":"2024-07-12","current":23.313894,"twenty":-71.810291,"median":24.273321,"eighty":28.980357,"marketCap":13183616},{"date":"2024-07-19","current":21.771249,"twenty":-70.527871,"median":24.005484,"eighty":28.783514,"marketCap":12305792},{"date":"2024-07-26","current":19.871565,"twenty":-67.981499,"median":23.548157,"eighty":28.579978,"marketCap":11236980},{"date":"2024-08-02","current":17.380948,"twenty":-63.611082,"median":23.313894,"eighty":28.402846,"marketCap":9828784},{"date":"2024-08-09","current":14.824233,"twenty":14.824233,"median":22.666232,"eighty":28.339976,"marketCap":8393176},{"date":"2024-08-16","current":14.891311,"twenty":14.824233,"median":22.428658,"eighty":26.393551,"marketCap":8432800},{"date":"2024-08-23","current":16.505019,"twenty":14.824233,"median":21.843651,"eighty":26.38192,"marketCap":9347200},{"date":"2024-08-30","current":15.221442,"twenty":14.891311,"median":21.615595,"eighty":26.235018,"marketCap":8617712},{"date":"2024-09-06","current":14.786956,"twenty":14.816778,"median":21.03365,"eighty":26.21652,"marketCap":8375904},{"date":"2024-09-13","current":18.291286,"twenty":14.783803,"median":19.997266,"eighty":26.012425,"marketCap":10355072},{"date":"2024-09-20","current":25.287335,"twenty":14.816778,"median":19.871565,"eighty":26.012425,"marketCap":14325600},{"date":"2024-09-27","current":18.961375,"twenty":14.877895,"median":19.084343,"eighty":25.954106,"marketCap":10769600},{"date":"2024-10-04","current":21.913118,"twenty":15.042266,"median":20.067523,"eighty":26.126798,"marketCap":12454128},{"date":"2024-10-11","current":22.176748,"twenty":15.165199,"median":20.049509,"eighty":25.99115,"marketCap":12598400},{"date":"2024-10-18","current":32.898839,"twenty":15.206634,"median":20.803771,"eighty":26.126798,"marketCap":18694400},{"date":"2024-10-25","current":23.358148,"twenty":15.219487,"median":21.352319,"eighty":26.21652,"marketCap":13270992},{"date":"2024-11-01","current":27.487373,"twenty":15.232907,"median":21.771249,"eighty":26.583872,"marketCap":15603728},{"date":"2024-11-08","current":26.826792,"twenty":15.38624,"median":21.882165,"eighty":26.827702,"marketCap":15231872},{"date":"2024-11-15","current":22.217928,"twenty":15.464941,"median":22.207911,"eighty":26.517352,"marketCap":12598400},{"date":"2024-11-22","current":19.532206,"twenty":15.526206,"median":22.192329,"eighty":26.402839,"marketCap":11076432},{"date":"2024-11-29","current":19.712189,"twenty":15.580772,"median":21.882165,"eighty":26.386572,"marketCap":11184128},{"date":"2024-12-06","current":18.691913,"twenty":15.639248,"median":21.771249,"eighty":26.293779,"marketCap":10607040},{"date":"2024-12-13","current":18.611126,"twenty":15.691094,"median":21.352319,"eighty":26.221145,"marketCap":10566400},{"date":"2024-12-20","current":7.102414,"twenty":15.639248,"median":20.803771,"eighty":26.151136,"marketCap":10058400},{"date":"2024-12-27","current":7.471029,"twenty":15.444399,"median":20.742686,"eighty":26.108587,"marketCap":10592816},{"date":"2025-01-03","current":10.196837,"twenty":15.213623,"median":20.067523,"eighty":26.07693,"marketCap":14427200},{"date":"2025-01-10","current":10.034934,"twenty":14.891311,"median":20.043836,"eighty":25.962557,"marketCap":14183360},{"date":"2025-01-17","current":9.907617,"twenty":14.749465,"median":19.895277,"eighty":25.951993,"marketCap":14008608},{"date":"2025-01-24","current":9.563114,"twenty":13.631492,"median":19.697706,"eighty":25.85141,"marketCap":13512800},{"date":"2025-01-31","current":8.48834,"twenty":10.018271,"median":19.532206,"eighty":25.746589,"marketCap":11988800},{"date":"2025-02-07","current":7.730432,"twenty":9.882149,"median":19.361654,"eighty":25.46422,"marketCap":10919968},{"date":"2025-02-14","current":7.130829,"twenty":9.483748,"median":19.090069,"eighty":25.309589,"marketCap":10081768},{"date":"2025-02-21","current":7.314786,"twenty":8.865676,"median":18.969464,"eighty":25.26403,"marketCap":10361168},{"date":"2025-02-28","current":5.889209,"twenty":8.594149,"median":18.858804,"eighty":25.21486,"marketCap":8333232},{"date":"2025-03-07","current":6.028973,"twenty":8.100004,"median":18.691913,"eighty":25.173677,"marketCap":8536432},{"date":"2025-03-14","current":5.598897,"twenty":7.846255,"median":18.496802,"eighty":25.10156,"marketCap":7926832},{"date":"2025-03-21","current":5.968988,"twenty":7.540872,"median":18.291286,"eighty":25.033931,"marketCap":8451088},{"date":"2025-03-28","current":7.03753,"twenty":7.389256,"median":18.105135,"eighty":24.856699,"marketCap":9956800},{"date":"2025-04-04","current":6.201809,"twenty":7.119463,"median":17.654152,"eighty":24.701604,"marketCap":8778240},{"date":"2025-04-11","current":6.159082,"twenty":7.009081,"median":17.557752,"eighty":24.560727,"marketCap":8737600},{"date":"2025-04-17","current":6.305413,"twenty":6.892251,"median":17.348506,"eighty":24.472151,"marketCap":8938768},{"date":"2025-04-25","current":5.299322,"twenty":6.518915,"median":16.836333,"eighty":24.40328,"marketCap":7518400},{"date":"2025-05-02","current":4.437465,"twenty":6.31653,"median":16.510738,"eighty":24.325687,"marketCap":6301232},{"date":"2025-05-09","current":5.171449,"twenty":6.285391,"median":16.156269,"eighty":24.224718,"marketCap":7317232},{"date":"2025-05-16","current":6.695699,"twenty":6.181855,"median":15.685852,"eighty":24.063819,"marketCap":6908800},{"date":"2025-05-23","current":7.021962,"twenty":6.235146,"median":15.538955,"eighty":24.008491,"marketCap":7233920},{"date":"2025-05-30","current":8.164705,"twenty":6.285272,"median":15.423857,"eighty":24.005032,"marketCap":8397532},{"date":"2025-06-06","current":8.847265,"twenty":6.289683,"median":15.216555,"eighty":23.931629,"marketCap":9092468},{"date":"2025-06-13","current":8.179292,"twenty":6.306628,"median":15.080005,"eighty":23.644242,"marketCap":8402196},{"date":"2025-06-20","current":10.670242,"twenty":6.311489,"median":14.824233,"eighty":23.64022,"marketCap":10960400},{"date":"2025-06-27","current":11.716334,"twenty":6.315883,"median":14.760327,"eighty":23.456094,"marketCap":12034985},{"date":"2025-07-03","current":10.216346,"twenty":6.317177,"median":14.71349,"eighty":23.384943,"marketCap":10494000},{"date":"2025-07-11","current":10.261711,"twenty":6.410478,"median":11.716334,"eighty":23.359949,"marketCap":10540640},{"date":"2025-07-18","current":9.808428,"twenty":6.454657,"median":10.875077,"eighty":23.322745,"marketCap":10077038},{"date":"2025-07-25","current":9.671429,"twenty":6.462794,"median":10.624987,"eighty":23.130117,"marketCap":9934320},{"date":"2025-08-01","current":8.89955,"twenty":6.57431,"median":10.442049,"eighty":23.054884,"marketCap":9141440},{"date":"2025-08-08","current":8.26371,"twenty":6.676961,"median":10.261711,"eighty":22.850835,"marketCap":8488480},{"date":"2025-08-15","current":8.020396,"twenty":6.711807,"median":10.206559,"eighty":22.709857,"marketCap":8255280},{"date":"2025-08-22","current":7.944228,"twenty":6.718226,"median":10.054926,"eighty":22.653826,"marketCap":8198379},{"date":"2025-08-29","current":7.484931,"twenty":6.73937,"median":9.97069,"eighty":22.584141,"marketCap":7742240},{"date":"2025-09-05","current":9.159836,"twenty":6.821347,"median":9.934593,"eighty":22.562922,"marketCap":9467920},{"date":"2025-09-12","current":9.23611,"twenty":6.883125,"median":9.907617,"eighty":22.500907,"marketCap":9561200},{"date":"2025-09-19","current":8.862273,"twenty":6.893296,"median":9.771265,"eighty":22.442063,"marketCap":9188080},{"date":"2025-09-26","current":7.431141,"twenty":6.901678,"median":9.711704,"eighty":22.390539,"marketCap":7701314},{"date":"2025-10-03","current":7.413811,"twenty":6.942194,"median":9.659792,"eighty":22.276807,"marketCap":7680994},{"date":"2025-10-10","current":7.489961,"twenty":6.99974,"median":9.578721,"eighty":22.211918,"marketCap":7762274},{"date":"2025-10-17","current":7.128574,"twenty":6.974212,"median":9.51173,"eighty":22.189213,"marketCap":7396512},{"date":"2025-10-24","current":6.854291,"twenty":6.883125,"median":9.462569,"eighty":22.01857,"marketCap":7112031},{"date":"2025-10-31","current":6.186973,"twenty":6.854004,"median":9.33225,"eighty":21.875975,"marketCap":6421148},{"date":"2025-11-07","current":4.741629,"twenty":6.765339,"median":9.223624,"eighty":21.842138,"marketCap":4917461},{"date":"2025-11-14","current":4.19042,"twenty":6.696493,"median":9.126243,"eighty":21.797185,"marketCap":4348499},{"date":"2025-11-21","current":3.92273,"twenty":6.462068,"median":9.081059,"eighty":21.677857,"marketCap":4064018},{"date":"2025-11-28","current":4.258196,"twenty":6.343606,"median":9.054357,"eighty":21.613946,"marketCap":4754901},{"date":"2025-12-05","current":4.259674,"twenty":6.293615,"median":8.88422,"eighty":21.40415,"marketCap":4754901},{"date":"2025-12-12","current":4.514242,"twenty":6.192907,"median":8.860854,"eighty":21.069359,"marketCap":5039382},{"date":"2025-12-19","current":5.42375,"twenty":6.139436,"median":8.843088,"eighty":20.941698,"marketCap":6055386},{"date":"2025-12-26","current":4.946749,"twenty":6.043228,"median":8.826007,"eighty":20.793652,"marketCap":5527064},{"date":"2026-01-02","current":4.114478,"twenty":6.028003,"median":8.79797,"eighty":20.753178,"marketCap":4592340},{"date":"2026-01-09","current":4.520095,"twenty":5.916655,"median":8.737897,"eighty":20.742686,"marketCap":5039382},{"date":"2026-01-16","current":4.304481,"twenty":5.809528,"median":8.606,"eighty":20.122966,"marketCap":4795541},{"date":"2026-01-23","current":4.012602,"twenty":5.729394,"median":8.586921,"eighty":20.078612,"marketCap":4470419},{"date":"2026-01-30","current":3.980203,"twenty":5.598444,"median":8.507076,"eighty":20.055999,"marketCap":4429779},{"date":"2026-02-06","current":4.032698,"twenty":5.480595,"median":8.444427,"eighty":20.045692,"marketCap":4483424},{"date":"2026-02-13","current":37.103077,"twenty":5.392255,"median":8.400514,"eighty":20.055999,"marketCap":41232559},{"date":"2026-02-20","current":76.39379,"twenty":5.417434,"median":8.490691,"eighty":20.746883,"marketCap":84923940},{"date":"2026-02-27","current":94.703469,"twenty":5.466384,"median":8.569807,"eighty":21.300488,"marketCap":105161940},{"date":"2026-03-06","current":178.696051,"twenty":5.550181,"median":8.593838,"eighty":21.842138,"marketCap":198597189},{"date":"2026-03-13","current":194.105286,"twenty":5.592612,"median":8.694472,"eighty":22.211918,"marketCap":215430665},{"date":"2026-03-20","current":93.116553,"twenty":5.596494,"median":8.786233,"eighty":22.500907,"marketCap":103270538},{"date":"2026-03-27","current":101.552611,"twenty":5.597991,"median":8.826007,"eighty":22.732806,"marketCap":112727547},{"date":"2026-04-02","current":14.162453,"twenty":5.599593,"median":8.843088,"eighty":23.069529,"marketCap":15698634}],"updateTime":1775351938059},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NCI\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1123570596","title":"JACOBIO-B (01167) Presents Preclinical Data for Pan-KRAS Inhibitor JAB-23E73 at the 2025 AACR-NCI-EORTC International Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1123570596","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123570596?lang=en_us&edition=fundamental","pubTime":"2025-10-24 06:14","pubTimestamp":1761257650,"startTime":"0","endTime":"0","summary":"JACOBIO-B (01167) announced that it will present preclinical data for its oral, highly potent Pan-KRAS inhibitor JAB-23E73 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","BK1574","BK1161","NCI","01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577539014","title":"BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2577539014","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577539014?lang=en_us&edition=fundamental","pubTime":"2025-10-24 04:05","pubTimestamp":1761249900,"startTime":"0","endTime":"0","summary":"Data demonstrate potent suppression of MAPK signaling and viability in KRAS mutant cell lines, as well as anti-tumor activity across multiple KRASG12D and KRASG12V cell-derived xenograft (CDX) modelsB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/23/3172449/0/en/BBOT-Presents-Preclinical-Data-Demonstrating-Potential-of-BBO-11818-as-a-Potent-panKRAS-Inhibitor-at-the-2025-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01336","BBOT","NCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577958432","title":"Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2577958432","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577958432?lang=en_us&edition=fundamental","pubTime":"2025-10-24 00:30","pubTimestamp":1761237000,"startTime":"0","endTime":"0","summary":"Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with advanced solid tumors, including ovarian, endometrial, and non-small cell lung ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/23/3172321/0/en/Zymeworks-Presents-Initial-Clinical-Data-from-the-Phase-1-trial-of-ZW191-an-Antibody-Drug-Conjugate-Targeting-Folate-Receptor-at-AACR-NCI-EORTC-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01336","NCI","BK4080","BK1584","ADC","BK1550","ORR","BK4588","BK4585","LU0572939691.SGD","LU0264606111.USD","BK1184","ET","BK4561","BK4231","BK4202","BK4144","LU0572940350.SGD","BK4590","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577584321","title":"ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2577584321","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577584321?lang=en_us&edition=fundamental","pubTime":"2025-10-24 00:30","pubTimestamp":1761237000,"startTime":"0","endTime":"0","summary":"-Two poster presentations showcase best- and first-in-class potential of ALX2004, a novel, antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors -Robust body of preclinical d","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/23/3172323/0/en/ALX-Oncology-Announces-Preclinical-Data-and-Phase-1-Trial-in-Progress-Presentations-of-ALX2004-a-Novel-EGFR-Targeted-ADC-at-2025-AACR-NCI-EORTC-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572939691.SGD","ALX","BK4097","LU0264606111.USD","BK1584","BK4202","BK1550","BK4231","LU0572940350.SGD","01336","BK1184","ADC","LU2065732104.USD","PRGS","BK4080","NCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154600470","title":"HUTCHMED (00013) Unveils HMPL-A251 Data at AACR-NCI-EORTC Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1154600470","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154600470?lang=en_us&edition=fundamental","pubTime":"2025-10-23 08:21","pubTimestamp":1761178899,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced the presentation of preclinical data for HMPL-A251 at the AACR-NCI-EORTC Molecular Targeted Therapy and Cancer Treatment International Conference, held from October 22 to...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","NCI","BK4588","BK4585","00013","BK1587","BK4202","HCM","BK1588","BK4531","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577345425","title":"HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2577345425","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577345425?lang=en_us&edition=fundamental","pubTime":"2025-10-23 08:00","pubTimestamp":1761177600,"startTime":"0","endTime":"0","summary":"— First investigational drug candidate using the HUTCHMED ATTC technology platform to create potent targeted therapy payloads while mitigating related toxicities — —Unique, highly potent PI3K/PIKK inh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/23/3171612/0/en/HUTCHMED-Highlights-HMPL-A251-Data-Presented-at-the-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","LU0572940350.SGD","BK4139","LU0264606111.USD","BK1584","BK4539","BK1550","BK1184","BK1191","BK4202","00013","LU0572939691.SGD","NCI","BK1588","01336","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577332319","title":"Arvinas to Present Preclinical Data for ARV-806, a PROTAC KRAS G12D Degrader, at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2577332319","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577332319?lang=en_us&edition=fundamental","pubTime":"2025-10-23 04:00","pubTimestamp":1761163200,"startTime":"0","endTime":"0","summary":"NEW HAVEN, Conn., Oct.  22, 2025  (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/22/3171450/0/en/Arvinas-to-Present-Preclinical-Data-for-ARV-806-a-PROTAC-KRAS-G12D-Degrader-at-the-2025-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572940350.SGD","LENZ","BK1584","01336","NCI","BK4007","LU0572939691.SGD","LU0264606111.USD","BK1184","BK1550","BK4139","BK4202","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577041394","title":"I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2577041394","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577041394?lang=en_us&edition=fundamental","pubTime":"2025-10-23 00:35","pubTimestamp":1761150900,"startTime":"0","endTime":"0","summary":"Updated Phase 1 givastomig monotherapy data show an impressive 18% ORR in metastatic gastric cancer patients who had received at least two prior lines of therapy. Responses were observed over a dose r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/22/3171382/0/en/I-Mab-To-Present-Positive-Updated-Givastomig-Monotherapy-Data-at-2025-AACR-NCI-EORTC-Molecular-Targets-and-Cancer-Therapeutics-Conference-on-October-23-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","BK4225","BK1584","LU0572939691.SGD","BK1184","NCI","PR","HR","LU0572940350.SGD","LENZ","BK1550","BK4505","BK4526","BK4203","BK4539","01336","LU0264606111.USD","ORR","BK4202","BK4139","IMAB","SD","BK4535","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575291296","title":"I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2575291296","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575291296?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:00","pubTimestamp":1760439600,"startTime":"0","endTime":"0","summary":"The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held October 22-26 in Boston, Massachusetts ROCKVILLE, Md., Oct.  14, 2025  (GLOBE NEWSWIRE) -- I-Mab (NA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/14/3166006/0/en/I-Mab-to-Present-Short-Talk-on-Updated-Givastomig-Monotherapy-Data-at-the-2025-AACR-NCI-EORTC-Molecular-Targets-and-Cancer-Therapeutics-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","LU0572940350.SGD","BK4505","BK4526","BK4139","LU0264606111.USD","BK4535","BK1584","BK4539","BK1550","BK1184","BK4202","IMAB","LU0572939691.SGD","NCI","01336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575428062","title":"Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2575428062","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575428062?lang=en_us&edition=fundamental","pubTime":"2025-10-14 04:05","pubTimestamp":1760385900,"startTime":"0","endTime":"0","summary":"Presentations feature data from first-in-human Phase 1 study including Cyclin E1 biomarker findings, supporting late-stage development of azenosertibSAN DIEGO, Oct.  13, 2025  (GLOBE NEWSWIRE) -- Zent","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/13/3165795/0/en/Zentalis-Pharmaceuticals-Announces-Four-Azenosertib-Posters-Presentations-at-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1184","BK4139","BK1550","BK4007","BK1584","BK4539","BK4202","LENZ","LU0264606111.USD","LU0572940350.SGD","LU0572939691.SGD","NCI","01336","PROC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575280607","title":"Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2575280607","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575280607?lang=en_us&edition=fundamental","pubTime":"2025-10-14 04:05","pubTimestamp":1760385900,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Oct.  13, 2025  (GLOBE NEWSWIRE) -- Boundless Bio, (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/13/3165792/0/en/Boundless-Bio-Announces-Upcoming-Presentation-at-the-2025-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0077335932.USD","RNR","LU0572940350.SGD","BK4202","BK4539","BK1184","LENZ","LU0572939691.SGD","BK4019","LU2244417387.USD","LU2413666426.HKD","BK4007","NCI","BOLD","LU2413666699.HKD","LU0187121727.USD","LU0264606111.USD","LU0347712357.USD","LU1721428933.USD","BK1584","01336","BK1550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575543280","title":"PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2575543280","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575543280?lang=en_us&edition=fundamental","pubTime":"2025-10-14 04:01","pubTimestamp":1760385660,"startTime":"0","endTime":"0","summary":"Oral presentation to highlight initial data from ongoing pivotal Phase 2 study of rezatapopt, a first-in-class precision oncology investigational therapy, in patients with advanced solid tumors harbor","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/13/3165785/0/en/PMV-Pharmaceuticals-to-Present-Rezatapopt-Pivotal-Phase-2-Initial-Analysis-and-Natural-History-Study-Results-at-the-2025-AACR-NCI-EORTC-International-Conference-on-Molecular-Target.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1550","BK4007","BK4202","LU0264606111.USD","BK1584","LU0572940350.SGD","BK1184","NCI","BK4139","PMVP","LENZ","BK4539","LU0572939691.SGD","01336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575028051","title":"Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2575028051","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575028051?lang=en_us&edition=fundamental","pubTime":"2025-10-14 04:00","pubTimestamp":1760385600,"startTime":"0","endTime":"0","summary":"Preliminary data presented at the AACR-NCI-EORTC conference will provide insights into the potential of ZW191 in patients with advanced solid tumors, including ovarian cancer, endometrial cancer, and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/13/3165776/0/en/Zymeworks-to-Present-Clinical-Data-from-the-Phase-1-trial-of-ZW191-an-Antibody-Drug-Conjugate-Targeting-Folate-Receptor-at-AACR-NCI-EORTC-International-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCI","BK4581","BK1184","BK4585","LU0572940350.SGD","BK4588","BK4231","BK4080","BK4202","BK1584","ET","ADC","LU0572939691.SGD","BK4561","BK4590","01336","LU0264606111.USD","BK4144","BK1550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575228307","title":"Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2575228307","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575228307?lang=en_us&edition=fundamental","pubTime":"2025-10-14 00:00","pubTimestamp":1760371200,"startTime":"0","endTime":"0","summary":"- Plenary session oral presentation: Friday, October 24 10:00 -11:40 a.m. ET - Poster presentation on preclinical evaluation of petosemtamab on cancer stem cells: Friday, October 24 12:30-4:00 p.m. ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/13/3165684/37568/en/Merus-Announces-Petosemtamab-in-Metastatic-Colorectal-Cancer-Abstract-Selected-for-Plenary-Session-Oral-Presentation-at-the-AACR-NCI-EORTC-International-Conference-on-Molecular-Tar.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","LU0572940350.SGD","BK4139","LU0264606111.USD","BK1584","BK4539","BK1550","BK1184","BK4202","LU0572939691.SGD","NCI","01336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575074283","title":"Avacta to Present First Dual Payload pre|CISION® Medicines Data at the 2025 EORTC-NCI-AACR International Conference on Molecular Targets Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2575074283","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575074283?lang=en_us&edition=fundamental","pubTime":"2025-10-14 00:00","pubTimestamp":1760371200,"startTime":"0","endTime":"0","summary":"Groundbreaking oncology development with the first dual payload peptide drug conjugate platform, establishing Avacta as a leader in combination therapy innovationLONDON and PHILADELPHIA, Oct.  13, 202","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/13/3165666/0/en/Avacta-to-Present-First-Dual-Payload-pre-CISION-Medicines-Data-at-the-2025-EORTC-NCI-AACR-International-Conference-on-Molecular-Targets-Symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572939691.SGD","LU0264606111.USD","BK1584","LU0572940350.SGD","BK1550","01336","BK1184","NCI","BK4202","MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2573946823","title":"3 Apparel Stocks See Sharp Drop In Momentum Rankings This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2573946823","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573946823?lang=en_us&edition=fundamental","pubTime":"2025-10-08 16:00","pubTimestamp":1759910400,"startTime":"0","endTime":"0","summary":"3 apparel stocks—Allbirds, Neo-Concept International, and Shoe Carnival—showed sharp momentum declines, dropping in momentum rankings.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/08/Stock-market-chaos.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/08/Stock-market-chaos.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/10/48093619/3-apparel-stocks-see-sharp-drop-in-momentum-rankings-this-week","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/10/48093619/3-apparel-stocks-see-sharp-drop-in-momentum-rankings-this-week","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["VOO","NQmain","SCVL","OEX","SH","QLD","SDS","USAW.SI","BK4534","IVV","SQQQ","SPY","TQQQ","BK4550","MESmain","BK4146","BK4581","UPRO","USJW.SI","BK4504","FDN","NCI","BK4561","QID","MNQmain",".IXIC","BK4094","OEF","BK4593",".SPX","BK4588","BK4585","NVIW.SI","BK4202","ESmain","SSO","SPXU","BK4559","PSQ","BIRD","TSYW.SI"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2573934714","title":"Shell third quarter 2025 update note","url":"https://stock-news.laohu8.com/highlight/detail?id=2573934714","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573934714?lang=en_us&edition=fundamental","pubTime":"2025-10-07 14:00","pubTimestamp":1759816800,"startTime":"0","endTime":"0","summary":"The following is an update to the third quarter 2025 outlook and gives an overview of our current expectations for the third quarter. Outlooks presented may vary from the actual third quarter 2025 res","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/07/3162217/0/en/Shell-third-quarter-2025-update-note.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","BK4006","MT","NCI","BK4561"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":77,"code":"91000000","status":"200"}]}}